Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeHOSPITALSNew FDA-Approved HeartLight X3 System for Cardiac Ablations Is Available at Delray...

New FDA-Approved HeartLight X3 System for Cardiac Ablations Is Available at Delray Medical Center: First in Palm Beach County, Florida

HeartLight X3 Endoscopic Ablation System Offers Symptom Relief for South Florida Area Patients

Delray Medical Center, part of the Palm Beach Health Network, is the first hospital in Palm Beach County to offer patients The HeartLight X3 System for cardiac ablations.  This procedure offers some of the most advanced treatments for patients with atrial fibrillation, the most common heart rhythm disorder.  Interventional cardiologist Dr. Mark Freher is the first surgeon to perform the procedure in our area using the system’s miniaturized camera and advanced laser technology.

“At Delray Medical Center, we are committed to innovation and offering patients early access to many of the latest cardiac treatment advancements, including devices like the HeartLight X3 System,” said Dr. Mark Freher, electrophysiologist on staff at Delray Medical Center. “We have taken the necessary steps to perform surgical procedures in a safe and secure environment, and our community can rest assured that we have the appropriate supplies and protocols in place.”

The HeartLight X3 Endoscopic Ablation System, developed by CardioFocus Inc.,  is designed for physicians to perform pulmonary vein isolation (PVI) procedures with accuracy, precision, and confidence. The PVI procedure creates areas of scar tissue around the pulmonary veins to block the electrical signals that cause arrhythmia. While older treatments rely on x-ray or mapping support for guidance, the X3 System’s innovative HeartLight catheter is equipped with a miniature video camera and “headlight” to deliver a direct, live-action view of the inside of the heart. The system also enables the physician to customize the amount of laser energy used during the procedure based upon the patient’s specific needs, and HeartLight’s unique balloon design adapts to the heart’s specific anatomy.

“I want to congratulate Dr. Freher and our cardiac team on becoming the first in Palm Beach County to perform this advanced procedure,” said Maggie Gill, chief executive officer of the Palm Beach Health Network and Delray Medical Center.  It is very rewarding to be able to continue to bring some of the latest medical innovations to our area, and we remain on the forefront of the latest cardiac treatment options.”

AFib is a serious condition that causes a quick, often chaotic heartbeat. Left untreated it can lead to weakness, breathlessness, fainting and a decreased quality of life. In addition, AFib patients face an increased risk of stroke, which is the fifth leading cause of death in the state of Florida. With proper treatment, patients affected by this debilitating condition can get safe symptom relief.


Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy